Skip to main content
. 2012 Nov 7;7(11):e49056. doi: 10.1371/journal.pone.0049056

Figure 3. UPDRS-III in ON condition in PD patients (N = 12) during the study.

Figure 3

The UPDRS-III score before implantation (mON) in session 1 after administration of 250 mg levodopa/carbidopa; in session 2 within 1–3 days after implantation of the electrode bilaterally to STN; in session 3 one month after implantation; and in session 4 one year after implantation examined each time with STN DBS ON (sON state) always with antiparkinsonian medication withdrawn; UPDRS-III – error bars (mean and SD); * (p<0.05), *** (p<0.001).